Skip to main content
Top
Published in: European Radiology 3/2006

01-03-2006 | Vascular-Interventional

Total-body 3D magnetic resonance angiography influences the management of patients with peripheral arterial occlusive disease

Published in: European Radiology | Issue 3/2006

Login to get access

Abstract

High-resolution total-body 3D MR angiography (MRA) has recently become available, revealing additional clinically relevant disease in patients with peripheral arterial occlusive disease (PAOD). However, the actual impact of total-body MRA on patient management in patients with PAOD has not been investigated so far. Two hundred forty-nine consecutive patients with angiographically proven PAOD were prospectively examined by means of contrast-enhanced total-body 3D MRA on a 1.5-T MR scanner. All correlative imaging studies performed within 60 days of total-body MRA were included in the efficacy analysis. Additional clinically relevant disease (luminal narrowing >50%, aneurysmal changes or dissections) was found in 73 segments (52 patients), including the renal arteries (36 segments), carotid arteries (28 segments), subclavian arteries (four segments) and abdominal aortic aneurysms (AAA) (five segments). Of the 73 segments, 36 were deemed necessary for further investigation by means of focused MRA examinations; the diagnosis was confirmed in all cases. Within the 60-day follow-up period, interventional or surgical therapy outside the peripheral arterial tree was performed in nine patients (11 segments), including carotid endatherectomy and renal artery angioplasty. The outlined total-body 3D MRA approach permits a comprehensive evaluation of the arterial system in patients with atherosclerosis and does indeed have an impact on patient management in patients with PAOD.
Literature
1.
go back to reference Rutkow IM, Ernst CB (1986) An analysis of vascular surgical manpower requirements and vascular surgical rates in the United States. J Vasc Surg 3:74–83CrossRefPubMed Rutkow IM, Ernst CB (1986) An analysis of vascular surgical manpower requirements and vascular surgical rates in the United States. J Vasc Surg 3:74–83CrossRefPubMed
2.
go back to reference Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC) (2000) J Vasc Surg 31, part 2(Suppl):S5 Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC) (2000) J Vasc Surg 31, part 2(Suppl):S5
3.
go back to reference Shellock FG, Kanal E (1999) Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 10:477–484CrossRefPubMed Shellock FG, Kanal E (1999) Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 10:477–484CrossRefPubMed
4.
go back to reference Prince MR (1994) Gadolinium-enhanced MR aortography. Radiology 191:155–164PubMed Prince MR (1994) Gadolinium-enhanced MR aortography. Radiology 191:155–164PubMed
5.
go back to reference Prince MR, Narasimham DL, Stanley JC, Chenevert TL, Williams DM, Marx MV, Cho KJ (1995) Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 197:785–792PubMed Prince MR, Narasimham DL, Stanley JC, Chenevert TL, Williams DM, Marx MV, Cho KJ (1995) Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 197:785–792PubMed
6.
go back to reference Meaney JF, Weg JG, Chenevert TL, Stafford-Johnson D, Hamilton BH, Prince MR (1997) Diagnosis of pulmonary embolism with magnetic resonance angiography. N Engl J Med 336:1422–1427CrossRefPubMed Meaney JF, Weg JG, Chenevert TL, Stafford-Johnson D, Hamilton BH, Prince MR (1997) Diagnosis of pulmonary embolism with magnetic resonance angiography. N Engl J Med 336:1422–1427CrossRefPubMed
7.
8.
go back to reference Herborn CU (2004) Peripheral contrast-enhanced 3D MRA with 1.0 M gadobutrol. Eur Radiol 14(Suppl 5):M23–M25PubMed Herborn CU (2004) Peripheral contrast-enhanced 3D MRA with 1.0 M gadobutrol. Eur Radiol 14(Suppl 5):M23–M25PubMed
9.
go back to reference Herborn CU (2004) On the difference between 0.5-M and 1.0-M gadolinium chelates for 3D MR angiography. Eur Radiol 14(Suppl 5):M21–M22PubMed Herborn CU (2004) On the difference between 0.5-M and 1.0-M gadolinium chelates for 3D MR angiography. Eur Radiol 14(Suppl 5):M21–M22PubMed
10.
go back to reference Meaney JF, Ridgway JP, Chakraverty S et al (1999) Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology 211:59–67PubMed Meaney JF, Ridgway JP, Chakraverty S et al (1999) Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology 211:59–67PubMed
11.
go back to reference Ho KY, Leiner T, de Haan MW et al (1998) Peripheral vascular tree stenoses: evaluation with moving-bed infusion-tracking MR angiography. Radiology 206:683–692PubMed Ho KY, Leiner T, de Haan MW et al (1998) Peripheral vascular tree stenoses: evaluation with moving-bed infusion-tracking MR angiography. Radiology 206:683–692PubMed
12.
go back to reference Ruehm SG, Goyen M, Barkhausen J et al (2001) Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 357:1086–1091PubMedCrossRef Ruehm SG, Goyen M, Barkhausen J et al (2001) Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 357:1086–1091PubMedCrossRef
13.
go back to reference Goyen M, Quick HH, Debatin JF et al (2002) Whole-body three-dimensional MR angiography with a rolling table platform: initial clinical experience. Radiology 224:270–277PubMedCrossRef Goyen M, Quick HH, Debatin JF et al (2002) Whole-body three-dimensional MR angiography with a rolling table platform: initial clinical experience. Radiology 224:270–277PubMedCrossRef
14.
go back to reference Herborn CU, Goyen M, Quick HH et al (2004) Whole-body 3D MR angiography of patients with peripheral arterial occlusive disease. Am J Roentgenol 182:1427–1434 Herborn CU, Goyen M, Quick HH et al (2004) Whole-body 3D MR angiography of patients with peripheral arterial occlusive disease. Am J Roentgenol 182:1427–1434
15.
go back to reference Goyen M, Herborn CU, Kroger K, Lauenstein TC, Debatin JF, Ruehm SG (2003) Detection of atherosclerosis: systemic imaging for systemic disease with whole-body three-dimensional MR angiography-initial experience. Radiology 227:277–282PubMedCrossRef Goyen M, Herborn CU, Kroger K, Lauenstein TC, Debatin JF, Ruehm SG (2003) Detection of atherosclerosis: systemic imaging for systemic disease with whole-body three-dimensional MR angiography-initial experience. Radiology 227:277–282PubMedCrossRef
16.
go back to reference Ruehm SG, Goyen M, Quick HH et al (2000) Whole-body MRA on a rolling table platform (AngioSURF). RöFo 172:670–674PubMed Ruehm SG, Goyen M, Quick HH et al (2000) Whole-body MRA on a rolling table platform (AngioSURF). RöFo 172:670–674PubMed
17.
go back to reference Goyen M, Herborn CU, Lauenstein TC, Debatin JF, Bosk S, Ruehm SG (2002) Optimization of contrast dosage for gadobenate dimeglumine-enhanced high-resolution whole body 3D MR angiography. Invest Radiol 37:263–268PubMedCrossRef Goyen M, Herborn CU, Lauenstein TC, Debatin JF, Bosk S, Ruehm SG (2002) Optimization of contrast dosage for gadobenate dimeglumine-enhanced high-resolution whole body 3D MR angiography. Invest Radiol 37:263–268PubMedCrossRef
18.
go back to reference Goyen M, Ruehm SG, Debatin JF (2000) MR angiography: the role of contrast agents. Eur J Radiol 34:247–256PubMedCrossRef Goyen M, Ruehm SG, Debatin JF (2000) MR angiography: the role of contrast agents. Eur J Radiol 34:247–256PubMedCrossRef
19.
go back to reference Prince MR (1998) Contrast-enhanced MR angiography: theory and optimization. Magn Reson Imaging Clin N Am 6:257–267PubMed Prince MR (1998) Contrast-enhanced MR angiography: theory and optimization. Magn Reson Imaging Clin N Am 6:257–267PubMed
20.
go back to reference Kirchin MA, Pirovano G, Spinazzi A (1998) Gd-BOPTA (Gd-BOPTA): an overview. Invest Radiol 33:798–809PubMedCrossRef Kirchin MA, Pirovano G, Spinazzi A (1998) Gd-BOPTA (Gd-BOPTA): an overview. Invest Radiol 33:798–809PubMedCrossRef
21.
go back to reference Knopp EA (1996) The role of magnetic resonance angiography in the assessment of intracranial vascular disease. Neuroimaging Clin N Am 6:769–780PubMed Knopp EA (1996) The role of magnetic resonance angiography in the assessment of intracranial vascular disease. Neuroimaging Clin N Am 6:769–780PubMed
22.
go back to reference Patrux B, Laissy JP, Jouini S, Kawiecki W, Coty P, Thiebot J (1994) Magnetic resonance anigography (MRA) of the circle of Willis: a prospective comparison with conventional angiography in 54 subjects. Neuroradiology 36:193–197CrossRefPubMed Patrux B, Laissy JP, Jouini S, Kawiecki W, Coty P, Thiebot J (1994) Magnetic resonance anigography (MRA) of the circle of Willis: a prospective comparison with conventional angiography in 54 subjects. Neuroradiology 36:193–197CrossRefPubMed
23.
go back to reference Stock KW, Radue EW, Jacob AL, Bao XS, Steinbrich W (1995) Intracranial arteries: prospective blinded comparative study of MR angiography and DSA in 50 patients. Radiology 195:451–456PubMed Stock KW, Radue EW, Jacob AL, Bao XS, Steinbrich W (1995) Intracranial arteries: prospective blinded comparative study of MR angiography and DSA in 50 patients. Radiology 195:451–456PubMed
24.
go back to reference Manning WJ, Li W, Edelman RR (1993) A preliminary report comparing magnetic resonance coronary angiography with conventional angiography. N Engl J Med 328:828–832PubMedCrossRef Manning WJ, Li W, Edelman RR (1993) A preliminary report comparing magnetic resonance coronary angiography with conventional angiography. N Engl J Med 328:828–832PubMedCrossRef
25.
go back to reference Li D, Deshpande V (2001) Magnetic resonance imaging of coronary arteries. Top Magn Reson Imaging 12:337–347PubMedCrossRef Li D, Deshpande V (2001) Magnetic resonance imaging of coronary arteries. Top Magn Reson Imaging 12:337–347PubMedCrossRef
26.
go back to reference Kim WY, Danias PG, Stuber M et al (2001) Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 345:1863–1869CrossRefPubMed Kim WY, Danias PG, Stuber M et al (2001) Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 345:1863–1869CrossRefPubMed
27.
go back to reference Herborn CU, Schmidt M, Bruder O, Nagel E, Shamsi K, Barkhausen J (2004) MR coronary angiography with SH L 643 A: initial experience in patients with coronary artery disease. Radiology 233:567–573PubMedCrossRef Herborn CU, Schmidt M, Bruder O, Nagel E, Shamsi K, Barkhausen J (2004) MR coronary angiography with SH L 643 A: initial experience in patients with coronary artery disease. Radiology 233:567–573PubMedCrossRef
28.
go back to reference Prince MR, Chenevert TL, Foo TK, Londy FJ, Ward JS, Maki JH (1997) Contrast-enhanced abdominal MR angiography: optimization of imaging delay time by automating the detection of contrast material arrival in the aorta. Radiology 203:109–114PubMed Prince MR, Chenevert TL, Foo TK, Londy FJ, Ward JS, Maki JH (1997) Contrast-enhanced abdominal MR angiography: optimization of imaging delay time by automating the detection of contrast material arrival in the aorta. Radiology 203:109–114PubMed
29.
go back to reference Goyen M, Goehde SC, Herborn CU et al (2004) MR-based full-body preventative cardiovascular and tumor imaging: technique and preliminary experience. Eur Radiol 14(5):783–791CrossRefPubMed Goyen M, Goehde SC, Herborn CU et al (2004) MR-based full-body preventative cardiovascular and tumor imaging: technique and preliminary experience. Eur Radiol 14(5):783–791CrossRefPubMed
30.
go back to reference Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P (1999) SENSE: sensitivity encoding for fast MRI. Magn Reson Med 42:952–962CrossRefPubMed Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P (1999) SENSE: sensitivity encoding for fast MRI. Magn Reson Med 42:952–962CrossRefPubMed
31.
go back to reference Fink C, Ley S, Kroeker R, Requardt M, Kauczor HU, Bock M (2005) Time-resolved contrast-enhanced three-dimensional magnetic resonance angiography of the chest: combination of parallel imaging with view sharing (TREAT). Invest Radiol 40:40–48CrossRefPubMed Fink C, Ley S, Kroeker R, Requardt M, Kauczor HU, Bock M (2005) Time-resolved contrast-enhanced three-dimensional magnetic resonance angiography of the chest: combination of parallel imaging with view sharing (TREAT). Invest Radiol 40:40–48CrossRefPubMed
32.
go back to reference de Vries M, Nijenhuis RJ, Hoogeveen RM, de Haan MW, van Engelshoven JM, Leiner T (2005) Contrast-enhanced peripheral MR angiography using SENSE in multiple stations: feasibility study. J Magn Reson Imaging 21:37–45CrossRefPubMed de Vries M, Nijenhuis RJ, Hoogeveen RM, de Haan MW, van Engelshoven JM, Leiner T (2005) Contrast-enhanced peripheral MR angiography using SENSE in multiple stations: feasibility study. J Magn Reson Imaging 21:37–45CrossRefPubMed
33.
go back to reference Von Kemp K, van den Brande P, Peterson T et al (1997) Screening for concomitant diseases in peripheral vascular patients. Results of a systematic approach. Int Angiol 16:114–122PubMed Von Kemp K, van den Brande P, Peterson T et al (1997) Screening for concomitant diseases in peripheral vascular patients. Results of a systematic approach. Int Angiol 16:114–122PubMed
34.
go back to reference Hertzer NR, Beven EG, Young JR et al (1984) Coronary artery disease in peripheral vascular patients. A classification of 1,000 coronary angiograms and results of surgical management. Ann Surg 199:223–233PubMedCrossRef Hertzer NR, Beven EG, Young JR et al (1984) Coronary artery disease in peripheral vascular patients. A classification of 1,000 coronary angiograms and results of surgical management. Ann Surg 199:223–233PubMedCrossRef
35.
go back to reference Alexandrova NA, Gibson WC, Norris JW, Maggisano R (1996) Carotid artery stenosis in peripheral vascular disease. J Vasc Surg 23:645–649PubMedCrossRef Alexandrova NA, Gibson WC, Norris JW, Maggisano R (1996) Carotid artery stenosis in peripheral vascular disease. J Vasc Surg 23:645–649PubMedCrossRef
36.
go back to reference Marek J, Mills JL, Harvich J, Cui H, Fujitani RM (1996) Utility of routine carotid duplex screening in patients who have claudication. J Vasc Surg 24:572–577, discussion 577–579CrossRefPubMed Marek J, Mills JL, Harvich J, Cui H, Fujitani RM (1996) Utility of routine carotid duplex screening in patients who have claudication. J Vasc Surg 24:572–577, discussion 577–579CrossRefPubMed
37.
go back to reference Klop RB, Eikelboom BC, Taks AC et al (1991) Screening of the internal carotid arteries in patients with peripheral vascular disease by colour-flow duplex scanning. Eur J Vasc Surg 5:41–45CrossRefPubMed Klop RB, Eikelboom BC, Taks AC et al (1991) Screening of the internal carotid arteries in patients with peripheral vascular disease by colour-flow duplex scanning. Eur J Vasc Surg 5:41–45CrossRefPubMed
38.
go back to reference McDaniel MD, Cronenwett JL (1989) Basic data related to the natural history of intermittent claudication. Ann Vasc Surg 3:273–277PubMedCrossRef McDaniel MD, Cronenwett JL (1989) Basic data related to the natural history of intermittent claudication. Ann Vasc Surg 3:273–277PubMedCrossRef
39.
go back to reference Tode JF (1995) Endarterectomy for asymptomatic carotid artery stenosis. JAMA 274:1505–1507CrossRef Tode JF (1995) Endarterectomy for asymptomatic carotid artery stenosis. JAMA 274:1505–1507CrossRef
40.
go back to reference Barnett HJM, Eliasziw ME, Meldrum HE, Taylor DW (1996) Do the facts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients? Neurology 46:603–608PubMed Barnett HJM, Eliasziw ME, Meldrum HE, Taylor DW (1996) Do the facts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients? Neurology 46:603–608PubMed
41.
go back to reference Silvestrini M, Vernieri F, Pasqualetti P et al (2000) Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 283:2122–2127CrossRefPubMed Silvestrini M, Vernieri F, Pasqualetti P et al (2000) Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 283:2122–2127CrossRefPubMed
42.
go back to reference Warlow C (1996) Surgical treatment of asymptomatic carotid stenosis. Cerebrovasc Dis 6(Suppl):7–14CrossRef Warlow C (1996) Surgical treatment of asymptomatic carotid stenosis. Cerebrovasc Dis 6(Suppl):7–14CrossRef
43.
go back to reference Melton LJ, Bickerstaff LK, Hollier LH et al (1984) Changing incidence of abdominal aortic aneurysms: a population-based study. Am J Epidemiol 120:379–386PubMed Melton LJ, Bickerstaff LK, Hollier LH et al (1984) Changing incidence of abdominal aortic aneurysms: a population-based study. Am J Epidemiol 120:379–386PubMed
44.
go back to reference Lederle FA, Walker JM, Reinke DB (1988) Selective screening for abdominal aortic aneurysms with physical examination and ultrasound. Arch Intern Med 148:1753–1756CrossRefPubMed Lederle FA, Walker JM, Reinke DB (1988) Selective screening for abdominal aortic aneurysms with physical examination and ultrasound. Arch Intern Med 148:1753–1756CrossRefPubMed
45.
go back to reference Cooley DA, Carmichael MJ (1984) Abdominal aortic aneurysm. Circulation 70:5–6 Cooley DA, Carmichael MJ (1984) Abdominal aortic aneurysm. Circulation 70:5–6
46.
go back to reference Salerno TA, Hermandez P, Lynn RB (1981) Abdominal aortic aneurysm in the elderly. Can J Surg 24:71–72PubMed Salerno TA, Hermandez P, Lynn RB (1981) Abdominal aortic aneurysm in the elderly. Can J Surg 24:71–72PubMed
47.
go back to reference Weinstein MC, Stason WB (1977) Foundations of cost-effectiveness analysis for the health and medical practices. N Engl J Med 296:716–721PubMedCrossRef Weinstein MC, Stason WB (1977) Foundations of cost-effectiveness analysis for the health and medical practices. N Engl J Med 296:716–721PubMedCrossRef
48.
go back to reference Steinberg CR, Morton A, Steinberg I (1965) Measurement of the abdominal aorta after intravenous aortography in health and arteriosclerotic peripheral vascular disease. Am J Roentgenol 95:703–708 Steinberg CR, Morton A, Steinberg I (1965) Measurement of the abdominal aorta after intravenous aortography in health and arteriosclerotic peripheral vascular disease. Am J Roentgenol 95:703–708
49.
go back to reference Lederle FA, Johnson GR, Wilson SE et al (1997) Prevalence and associations of abdominal aortic aneurysm detected through screening. Ann Intern Med 126:441–449PubMed Lederle FA, Johnson GR, Wilson SE et al (1997) Prevalence and associations of abdominal aortic aneurysm detected through screening. Ann Intern Med 126:441–449PubMed
50.
go back to reference Frame PS, Fryback DG, Patterson C (1993) Screening for abdominal aortic aneurysm in men ages 60 to 80 years. A cost-effectiveness analysis. Ann Intern Med 119:411–416PubMed Frame PS, Fryback DG, Patterson C (1993) Screening for abdominal aortic aneurysm in men ages 60 to 80 years. A cost-effectiveness analysis. Ann Intern Med 119:411–416PubMed
51.
go back to reference Johansen K, Koepsell T (1986) Familial tendency for abdominal aortic aneurysms. JAMA 256:1934–1936CrossRefPubMed Johansen K, Koepsell T (1986) Familial tendency for abdominal aortic aneurysms. JAMA 256:1934–1936CrossRefPubMed
52.
go back to reference Scott RA, Wilson NM, Ashton HA, Kay DN (1995) Influence of screening on the incidence of ruptured abdominal aortic aneurysms: 5-year results of a randomized controlled study. Br J Surg 82:1066–1070PubMedCrossRef Scott RA, Wilson NM, Ashton HA, Kay DN (1995) Influence of screening on the incidence of ruptured abdominal aortic aneurysms: 5-year results of a randomized controlled study. Br J Surg 82:1066–1070PubMedCrossRef
Metadata
Title
Total-body 3D magnetic resonance angiography influences the management of patients with peripheral arterial occlusive disease
Publication date
01-03-2006
Published in
European Radiology / Issue 3/2006
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-005-0001-8

Other articles of this Issue 3/2006

European Radiology 3/2006 Go to the issue

Letter to the Editor

Author’s reply